Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This man-made peptide resembles the actions of naturally occurring GLP-1, a https://sociallweb.com/story6342448/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes